Skip to Main Content

Author Details

Johannes H A M Kaanders
Radboud University Medical Center
1987
285
60
PMIDPaper TitleJournal TitlePublished Year
38043360Value of routine follow-up for recurrence detection after treatment with curative intent for laryngeal squamous cell carcinoma.Eur J Surg Oncol2024
35118579Future steps in cardio-oncology-a national multidisciplinary survey among healthcare professionals in the Netherlands.J Cancer Surviv2023
37965060Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherapy to the PRIMary tumor only. Protocol of the PRIMO study.Clin Transl Radiat Oncol2023
37878160Quantitative and clinical implications of the EARL2 versus EARL1 [<sup>18</sup>F]FDG PET-CT performance standards in head and neck squamous cell carcinoma.EJNMMI Res2023
37331783[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription.Semin Radiat Oncol2023
36818021Validation of automated positive cell and region detection of immunohistochemically stained laryngeal tumor tissue using digital image analysis.J Pathol Inform2023
36565244Value of routine follow-up in oropharyngeal squamous cell cancer patients treated with curative intent.Head Neck2023
36942817Sentinel node identification in laryngeal and pharyngeal carcinoma after flexible endoscopy-guided tracer injection under topical anesthesia: A feasibility study.Head Neck2023
35248013Long-term cognitive, psychosocial, and neurovascular complications of unilateral head and neck irradiation in young to middle-aged adults.BMC Cancer2022
35587353Comparison of Patients With Head and Neck Cancer in Randomized Clinical Trials and Clinical Practice: A Systematic Review.JAMA Otolaryngol Head Neck Surg2022
35658993Head and neck cancer: high-end technology is no guarantee of high-quality care.Lancet2022
35776432High-Accuracy Nodal Staging of Head and Neck Cancer With USPIO-Enhanced MRI: A New Reading Algorithm Based on Node-to-Node Matched Histopathology.Invest Radiol2022
36581428Individualised follow-up for head and neck cancer-design of a prospective cohort study to assess its feasibility.BMJ Open2022
35871069Assessing radiation-induced carotid vasculopathy using ultrasound after unilateral irradiation: a cross-sectional study.Radiat Oncol2022
36047597Diagnostic test accuracy of sentinel lymph node biopsy in squamous cell carcinoma of the oropharynx, larynx, and hypopharynx: A systematic review and meta-analysis.Head Neck2022
32512074Author's response to letter to the editor regarding JHAM Kaanders et al. "Advances in cancer imaging require renewed radiotherapy dose and target volume concepts".Radiother Oncol2021
33807446Merkel Cell Carcinoma: New Trends.Cancers (Basel)2021
33634033Novel Diagnostic Approaches for Assessment of the Clinically Negative Neck in Head and Neck Cancer Patients.Front Oncol2021
33748441The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset.Clin Transl Radiat Oncol2021
34487765Radiotherapy as nose preservation treatment strategy for cancer of the nasal vestibule: The Dutch experience.Radiother Oncol2021
34352413Considerations for radiotherapy in Bloom Syndrome: A case series.Eur J Med Genet2021
31439447<sup>18</sup>F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival.Radiother Oncol2020
31805515Radiotherapy in the treatment of extracranial hemangiopericytoma/solitary fibrous tumor: Study from the Rare Cancer Network.Radiother Oncol2020
32100130Tumor control of cervical lymph node metastases of unknown primary origin: the impact of the radiotherapy target volume.Eur Arch Otorhinolaryngol2020
32093572Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review.Otolaryngol Head Neck Surg2020
33458320External validation of deep learning-based contouring of head and neck organs at risk.Phys Imaging Radiat Oncol2020
33137396Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures.Radiother Oncol2020
32634271Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancer.Cancer2020
32730830Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement.Radiother Oncol2020
32417345Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma.Radiother Oncol2020
32361663Advances in cancer imaging require renewed radiotherapy dose and target volume concepts.Radiother Oncol2020
32302681Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.Int J Radiat Oncol Biol Phys2020
32198613Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [<sup>68</sup>Ga]Ga-DOTA-E-[c(RGDfK)]<sub>2</sub> PET/CT.Eur J Nucl Med Mol Imaging2020
30474448Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial.Acta Oncol2019
31817870ACLY (ATP Citrate Lyase) Mediates Radioresistance in Head and Neck Squamous Cell Carcinomas and is a Novel Predictive Radiotherapy Biomarker.Cancers (Basel)2019
31668020Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes.Thorac Cancer2019
30005954Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of <sup>18</sup>F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting.Radiother Oncol2019
31400079Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.Cancer Med2019
31306734Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact.Int J Radiat Oncol Biol Phys2019
30730570Erratum: "Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers" [Med. Phys. 45 (7), 3449-3459 (2018)].Med Phys2019
30999660Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).Cancers (Basel)2019
30965213Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study.Eur J Cancer2019
31173429Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer.Head Neck2019
30458233Image Guided Brachytherapy for Cancer of the Nasal Vestibule: Local Control and Cosmesis.Int J Radiat Oncol Biol Phys2019
30536479Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy.Head Neck2019
29044881Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy.Head Neck2018
30160027Surgery, radiotherapy or a combined modality for jugulotympanic paraganglioma of Fisch class C and D.Clin Otolaryngol2018
29909898Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.Oral Oncol2018
29731161Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.Radiother Oncol2018
29763967Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.Med Phys2018
  • 1 - 50 of 285

Recommended Authors

Jason W Chan
University of California San Francisco
Career Start Year 2017
Number of shared co-authors 3
Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 6
Musaddiq J Awan
Medical College of Wisconsin
Career Start Year 2013
Number of shared co-authors 2
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 7
Katharine A Price
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 5
Daniel J Ma
Mayo Clinic
Career Start Year 2005
Number of shared co-authors 4
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 9
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 5
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 5
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 12
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 2
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 4
Barbara Bachtiary
Center for Proton Therapy, Paul Scherrer Institute
Career Start Year 2000
Number of shared co-authors 1
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 4
Beth M Beadle
Stanford University
Career Start Year 1999
Number of shared co-authors 4
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Christopher U Jones
Sutter Medical Center Sacramento
Career Start Year 1998
Number of shared co-authors 6
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 2
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 6
Karin Dieckmann
Medical University of Vienna
Career Start Year 1991
Number of shared co-authors 4
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 6
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 4
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Robert L Foote
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 5
David I Rosenthal
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 7
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 11
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 5
Michael Henke
Medical Center, University of Freiburg
Career Start Year 1984
Number of shared co-authors 2
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Johan Bussink
Radboud University, Nijmegen Medical Centre
Co-authored papers 93
Albert J van der Kogel
University of Wisconsin School of Medicine and Public Health
Co-authored papers 67
Paul N Span
Radboud University Medical Center
Co-authored papers 38
Esther G C Troost
German Cancer Research Center (DKFZ)
Co-authored papers 26
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers 14
Bianca A W Hoeben
Radboud University Medical Center
Co-authored papers 10
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Co-authored papers 6
Philippe Lambin
Maastricht University
Co-authored papers 6
Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers 5
Coen R N Rasch
Leiden University Medical Center
Co-authored papers 5
Fred C G J Sweep
Radboud University Medical Centre
Co-authored papers 4
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Erik Roelofs
Maastricht University Medical Centre+
Co-authored papers 3
Cary Oberije
Maastricht University Medical Centre
Co-authored papers 2
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Co-authored papers 2
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers 2
Adrian C Begg
The Netherlands Cancer Institute
Co-authored papers 2
Ludwig Dubois
Maastricht University
Co-authored papers 2
John A Lee
Institute of Experimental and Clinical Research
Co-authored papers 2
David R Raleigh
University of California san francisco
Co-authored papers 2
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 2
Mathieu Hatt
INSERM
Co-authored papers 2
Andre Dekker
Maastricht University Medical Centre
Co-authored papers 2
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers 2
David A Palma
University of Western Ontario
Co-authored papers 2
Lambertus A Kiemeney
Co-authored papers 1
Jeroen A W M van der Laak
Radboud University Medical Center
Co-authored papers 1
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Peter Hoskin
Mount Vernon Cancer Centre
Co-authored papers 1
Release 1.2